Irinotecan hydrochloride trihydrate loaded folic acid-tailored solid lipid nanoparticles for targeting colorectal cancer: development, characterization, and in vitro cytotoxicity study using HT-29 cells

References

• Abumanhal-Masarweh, H., et al., 2019. Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells. Journal of controlled release, 307, 331–341.
   PubMed Web of Science ®Google Scholar
• Aji Alex, M.R., et al., 2011. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. European journal of pharmaceutical sciences: official journal of the European federation for pharmaceutical sciences, 42(1–2), 11–18.
   PubMed Web of Science ®Google Scholar
• Bansal, T., et al., 2008. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies. Talanta, 76(5), 1015–1021.
   PubMed Web of Science ®Google Scholar
• Bera, K., et al., 2018. Porphyrin-gold nanomaterial for efficient drug delivery to cancerous cells. ACS omega, 3(4), 4602–4619.
   PubMed Web of Science ®Google Scholar
• Bhalekar, M.R., Upadhaya, P.G., and Madgulkar, A.R., 2016. Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-alpha ELISA. European journal of pharmaceutical sciences, 84, 1–8.
   PubMed Web of Science ®Google Scholar
• Bies, C., Lehr, C.M., and Woodley, J.F., 2004. Lectin-mediated drug targeting: history and applications. Advanced drug delivery reviews, 56(4), 425–435.
   PubMed Web of Science ®Google Scholar
• Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians, 68(6), 394–424.
   PubMed Web of Science ®Google Scholar
• Brearley, M.J., 2014. 16 - Chemotherapy. In: S.J. Langley-Hobbs, J.L. Demetriou, J.F. Ladlow, eds. Feline soft tissue and general surgery. Philadelphia, United States: W.B. Saunders, 161–167.
   Google Scholar
• Bunjes, H., Steiniger, F., and Richter, W., 2007. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir, 23(7), 4005–4011.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Westesen, K., and Koch, M., 1996. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. International journal of pharmaceutics, 129(1–2), 159–173.
   Web of Science ®Google Scholar
• Chalikwar, S.S., et al., 2012. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids and surfaces. B, biointerfaces, 97, 109–116.
   PubMed Web of Science ®Google Scholar
• Charasson, V., Haaz, M.C., and Robert, J., 2002. Determination of drug interactions occurring with the metabolic pathways of irinotecan. Drug metabolism and disposition, 30(6), 731–733.
   PubMed Web of Science ®Google Scholar
• Chiani, M., et al., 2018. Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin. Artificial cells, nanomedicine, and biotechnology, 46(4), 757–763.
   PubMed Web of Science ®Google Scholar
• Cho, H.J., et al., 2014. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. International journal of nanomedicine, 9, 495–504.
   PubMed Web of Science ®Google Scholar
• de Jong, F.A., et al., 2006. Role of pharmacogenetics in irinotecan therapy. Cancer letters, 234(1), 90–106.
   PubMed Web of Science ®Google Scholar
• Dong, L., et al., 2015. Preparation of concanavalin A-chelating magnetic nanoparticles for selective enrichment of glycoproteins. Analytical chemistry, 87(13), 6849–6853.
   PubMed Web of Science ®Google Scholar
• Esposito, E., et al., 2017. Progesterone lipid nanoparticles: scaling up and in vivo human study. European journal of pharmaceutics and biopharmaceutics, 119, 437–446.
   PubMed Web of Science ®Google Scholar
• Foroozandeh, P., and Aziz, A.A., 2018. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale research letters, 13(1), 339.
   PubMed Web of Science ®Google Scholar
• Fry, D.W., White, J.C., and Goldman, I.D., 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical biochemistry, 90(2), 809–815.
   PubMed Web of Science ®Google Scholar
• Gidwani, B., and Vyas, A., 2016. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box–Behnken design and response surface methodology. Artificial cells nanomedicine and biotechnology, 44(2), 571–580.
   PubMed Web of Science ®Google Scholar
• Granja, A., et al., 2019. EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers. Heliyon, 5(7), e02020.
   PubMed Web of Science ®Google Scholar
• Gupta, Y., Jain, A., and Jain, S.K., 2007. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. Journal of pharmacy and pharmacology, 59(7), 935–940.
   PubMed Web of Science ®Google Scholar
• Hofmann, C., et al., 2005. Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy. Anticancer research, 25(2A), 795–804.
   PubMed Web of Science ®Google Scholar
• Hu, F.Q., et al., 2002. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. International journal of pharmaceutics, 239(1-2), 121–128.
   PubMed Web of Science ®Google Scholar
• Hu, J., and Liu, Y., 2015. Cyclic strain enhances cellular uptake of nanoparticles. Journal of nanomaterials, 2015, 1.
   Web of Science ®Google Scholar
• ICH. 2003. ICH Q1A (R2): stability testing of new drug substances and products.
   Google Scholar
• Jain, A., et al., 2010. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine, 6(1), 179–190.
   PubMed Web of Science ®Google Scholar
• Kim, H., et al., 2017. Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles. Scientific reports, 7(1), 41090.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., et al., 1999. pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells. International journal of cancer, 83(4), 491–496.
   PubMed Web of Science ®Google Scholar
• Kushwaha, A.K., et al., 2013. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. Biomed research international, 2013, 1.
   Web of Science ®Google Scholar
• Lee, S.-E., et al., 2019. Hyaluronic acid-coated solid lipid nanoparticles to overcome drug-resistance in tumor cells. Journal of drug delivery science and technology, 50, 365–371.
   Web of Science ®Google Scholar
• Liu, J., et al., 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. International journal of pharmaceutics, 328(2), 191–195.
   PubMed Web of Science ®Google Scholar
• Maltas, E., Ozmen, M., and Cingilli Vural, H., 2013. Interaction of L-myc oncogene in breast cancer with irinotecan onto functionalized magnetic nanoparticles. Materials letters, 106, 8–10.
   Web of Science ®Google Scholar
• Morland, B., Platt, K., and Whelan, J.S., 2014. A phase II window study of irinotecan (CPT-11) in high risk Ewing sarcoma: a Euro-E.W.I.N.G. study. Pediatric blood and cancer, 61(3), 442–445.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S., Ray, S., and Thakur, R.S., 2009. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian journal of pharmaceutical sciences, 71(4), 349–358.
   PubMed Web of Science ®Google Scholar
• Muller, R.H., Mader, K., and Gohla, S., 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. European journal of pharmaceutics and biopharmaceutics, 50(1), 161–177.
   PubMed Web of Science ®Google Scholar
• Patel, M.H., Mundada, V.P., and Sawant, K.K., 2019. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug development and industrial pharmacy, 45(8), 1242–1257.
   PubMed Web of Science ®Google Scholar
• Pawar, A., et al., 2018. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artificial cells, nanomedicine, and biotechnology, 46(sup1), 347–361.
   PubMed Web of Science ®Google Scholar
• Peng, T.-X., et al., 2019. Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives. Colloids and surfaces B: biointerfaces, 181, 369–378.
   PubMed Web of Science ®Google Scholar
• Rajpoot, K., and Jain, S.K., 2018. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation. Artificial cells, nanomedicine, and biotechnology, 46(6), 1236–1247.
   PubMed Web of Science ®Google Scholar
• Roohinejad, S., et al., 2018. Solid lipid nanoparticles. In: S. Roohinejad, R. Greiner, I. Oey, J. Wen, eds. Emulsion-based systems for delivery of food active compounds: formation, application, health and safety. Hoboken, New Jersey, United States: John Wiley & Sons, 312.
   Google Scholar
• Saltz, L.B., 1997. Clinical use of irinotecan:current status and future considerations. Oncologist, 2(6), 402–409.
   PubMedGoogle Scholar
• Siegel, R.L., et al., 2017. Colorectal cancer statistics, 2017. CA: a cancer journal for clinicians, 67(3), 177–193.
   PubMed Web of Science ®Google Scholar
• Soni, N., et al., 2016. Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. Journal of colloid and interface science., 481, 107–116.
   PubMed Web of Science ®Google Scholar
• Sutradhar, K.B., and Amin, M.L., 2014. Nanotechnology in cancer drug delivery and selective targeting. ISRN nanotechnology, 2014, 1.
   Google Scholar
• Tamyurek, E., et al., 2015. Magnetic nanoparticles-serum proteins bioconjugates for binding of irinotecan. International journal of biological macromolecules, 73(0), 76–83.
   PubMed Web of Science ®Google Scholar
• Truzzi, E., et al., 2017. Self-assembled lipid nanoparticles for oral delivery of heparin-coated iron oxide nanoparticles for theranostic purposes. Molecules, 22(6), 963.
   PubMed Web of Science ®Google Scholar
• Ucar, E., et al., 2017. Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system. Applied radiation and isotopes, 119, 72–79.
   PubMed Web of Science ®Google Scholar
• Venishetty, V.K., et al., 2013. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine, 9(1), 111–121.
   PubMed Web of Science ®Google Scholar
• Vyas, A., et al., 2015. Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier. Colloids and surfaces B: biointerfaces, 131, 155–161.
   PubMed Web of Science ®Google Scholar
• Wang, F., et al., 2017. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Biomedicine and pharmacotherapy = biomedecine and pharmacotherapie, 86, 595–604.
   PubMed Web of Science ®Google Scholar
• Wang, G.-S., et al., 2011. Characterisation and antiproliferative activity of irinotecan and sulphonatocalixarene inclusion complex. Supramolecular chemistry, 23(6), 441–446.
   Web of Science ®Google Scholar
• Wissing, S.A., Kayser, O., and M, and, R.H., 2004. Solid lipid nanoparticles for parenteral drug delivery. Advanced drug delivery reviews, 56(9), 1257–1272.
   PubMed Web of Science ®Google Scholar
• Yang, X., et al., 2012. Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin. Journal of biomedical nanotechnology, 8(5), 834–842.
   PubMed Web of Science ®Google Scholar
• Yuan, Q., et al., 2014. Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. International journal of nanomedicine, 9, 4829–4846.
   PubMed Web of Science ®Google Scholar
• Zheng, G., et al., 2019. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomedicine and pharmacotherapy, 116, 109006.
   PubMed Web of Science ®Google Scholar